According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is -$2.00. In 2022 the company made an earnings per share (EPS) of -$2.12 a decrease over its 2021 EPS that were of $0.38.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.00 | -5.66% |
2022 | -$2.12 | -657.89% |
2021 | $0.38 | -110.44% |
2020 | -$3.64 | 295.65% |
2019 | -$0.92 | -60.34% |
2018 | -$2.32 | -85.73% |
2017 | -$16.26 | -23328.57% |
2016 | $0.07000 | -96.2% |
2015 | $1.84 | -48.6% |
2014 | $3.58 | 138.67% |
2013 | $1.50 | -33.33% |
2012 | $2.25 | -27.65% |
2011 | $3.11 | -16.4% |
2010 | $3.72 | 62.45% |
2009 | $2.29 | 186.25% |
2008 | $0.80 | -68.5% |
2007 | $2.54 | 296.88% |
2006 | $0.64 | -63.01% |
2005 | $1.73 | 232.69% |
2004 | $0.52 | -59.53% |
2003 | $1.28 | 65.81% |
2002 | $0.77 | 47.62% |
2001 | $0.52 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | -287.00% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -193.00% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -259.01% | ๐ซ๐ท France |
Merck MRK | $1.82 | -191.08% | ๐บ๐ธ USA |
AstraZeneca AZN | $1.98 | -199.25% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $3.50 | -275.04% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $3.71 | -285.55% | ๐ฎ๐ณ India |